Clinical trial
Effects of Noradrenaline Administration Combined With Restrictive Intraoperative Fluid Substitution on Blood Loss and Perioperative Outcome in Patients Undergoing Open Radical Cystectomy
NCT01276665 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Noradrenaline Administration Combined With Restrictive Intraoperative Fluid Substitution on Blood Loss and Perioperative Outcome in Patients Undergoing Open Radical Cystectomy
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- December 31, 2012
- Enrollment
- 190 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bladder cancer, urinary diversion